Veterinary Medicines

Canvac 8 DHPPiL vakcina A.U.V.

Authorised
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
  • Leptospira interrogans, serogroup Sejroe, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
  • Canine parainfluenza virus, Live
  • Canine parvovirus, Live
  • Canine adenovirus 2, Live
  • Canine distemper virus, Live
Download as PDF

Product identification

Medicine name:
Canvac 8 DHPPiL vakcina A.U.V.
Active substance:
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
  • Leptospira interrogans, serogroup Sejroe, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
  • Canine parainfluenza virus, Live
  • Canine parvovirus, Live
  • Canine adenovirus 2, Live
  • Canine distemper virus, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
  • Leptospira interrogans, serogroup Sejroe, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
  • Canine parainfluenza virus, Live
    3.00
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)/dose
  • Canine parvovirus, Live
    2.00
    log10 haemagglutination inhibiting unit(s)
    /
    1.00
    unit(s)/dose
  • Canine adenovirus 2, Live
    3.50
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)/dose
  • Canine distemper virus, Live
    2.70
    log 10 50% embryo infective dose
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Powder and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • BACS-VET Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dyntec spol. s r.o.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change: